Newsletter- All News is a comprehensive section of updated news and current trends, specifically curated to keep clinical trials, including breakthroughs in drug research, regulatory approvals, and advancements in study methodologies. Our news covers key trends in trial designs, patient recruitment strategies, and cutting-edge technologies shaping the future of clinical research
Showing 1–5 of 10 stories
Latest story
Takeda announced new data from three phase 3 LATITUDE psoriasis studies of zasocitinib (TAK-279), an...
Read story
Agreement Gives Tolerance Bio Worldwide Development Rights Outside Japan Tolerance Bio, Inc. has...
Read story
Funding Will Support U.S. Clinical Development in Extremely Preterm Infants Airway Therapeutics,...
Read story
Phase III Study Meets Primary Endpoint in Adults With DSWPD Vanda Pharmaceuticals Inc. has report...
Read story
Tremfya Meets Main Study Goals in Patients With Axial Involvement Johnson & Johnson has annou...
Read storyPage 1 of 2